O besity and type 2 diabetes have become major health challenges worldwide. Current data show that approximately 1.5 billion adults aged 20 years or older are overweight, and 10% are obese. 1 In the United States, one-third of the population meets the criteria for metabolic syndrome. 2, 3 Although lifestyle changes and lack of exercise are important risk factors for weight gain, 4,5 excessive caloric intake appears to be one key factor fueling the epidemic of obesity. Poor dietary habits negatively affect a broad range of cardiovascular functions and promote the onset of type 2 diabetes. 3
to stem the tide of the epidemics of type 2 diabetes and obesity, it is important to understand the relationship between obesity and insulin resistance, as well as the physiological processes that regulate their development.
Accumulating evidence suggests that the vascular endothelium regulates insulin action. In humans, states of obesity and insulin resistance are characterized by endothelial dysfunction, impaired vasodilation, and insulin resistance; 9 in rats, inhibition of endothelial nitric oxide (NO) synthase (eNOS) decreases insulin-stimulated uptake of glucose by skeletal muscle, suggesting that eNOS may be a key regulator of metabolic homeostasis. This role of eNOS is further corroborated by the observations that in mice deletion of the eNOS gene induces insulin resistance 10, 11 and impairs fatty acid oxidation. 12 Nevertheless, the role of eNOS in regulating metabolic changes that contribute to obesity under conditions of nutrient excess is not well-understood. In particular, it is unclear whether eNOS could prevent or attenuate diet-induced adiposity and insulin resistance.
To understand the metabolic role of eNOS, we studied the effects of high-fat diet in mice overexpressing eNOS. Our hypothesis was that increasing eNOS levels mitigates the effects of high-fat feeding by regulating adipose tissue metabolism. We found that eNOS transgenic (eNOS-TG) mice were resistant to diet-induced weight gain, but not glucose intolerance. These findings reveal a new antiobesogenic role of eNOS and its favorable influence on adipose tissue metabolism.
Methods

Animal Studies
The B6.BKS(D)-Lepr db /J (db/db) mice and C57BL/6J ( wild-type; WT) mice were purchased from The Jackson Laboratory (Bar Harbor, ME). The eNOS-TG mice, which express bovine eNOS under the control of the preproendothelin-1 promoter, 13 were maintained on the C57BL/6J background. At 8 weeks of age, male mice were placed on either a 10% low-fat diet (#D12450B; Research Diets) or a 60% high-fat diet (#D12492; Research Diets) and maintained for 6 to 15 additional weeks. Water and diet were provided ad libitum. Body weights were recorded weekly. During the weeks 7 and 13 of feeding, glucose and insulin tolerance tests were performed. Pyruvate tolerance tests were performed only after week 13 of feeding; all other parameters were evaluated after euthanasia. All procedures were approved by the University of Louisville Institutional Animal Care and Use Committee.
Expression Analyses
Tissue homogenates were prepared and used for Western blot protein expression analysis. For quantitative reverse-transcription polymerase chain reaction, RNA extracted from tissues was used to assess pgc1a, cytb6, gapdh, ppara, and pparg expression using commercially available primers (SABiosciences, Valencia, CA).
Glucose, Insulin, and Pyruvate Tolerance Tests
As described before, 14 glucose tolerance tests were performed after a 6-hour fast by injection (intraperitoneally) of D-glucose (1 mg/g) in sterile saline. Insulin tolerance tests were performed on nonfasted animals by interperitoneal injection of 1.5 U/kg Humulin R (Eli Lilly, Indianapolis, IN). After a 6-hour fast, pyruvate tolerance tests were performed as described. 15 
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Adipose Tissue Bioenergetic Measurements
The oxygen consumption rate and extracellular acidification rate of intact adipose tissue explants were measured using a Seahorse XF24 analyzer (Seahorse Bioscience, Billerica, MA). Briefly, freshly isolated epididymal adipose tissue was rinsed with unbuffered Dulbecco modified Eagle medium (pH 7.4). The adipose tissue was cut into sections, and 10 mg was placed in each well of an XF 24 Islet Capture Microplate (Seahorse Bioscience, Billerica, MA). The tissue was then covered with a screen, which allowed free perfusion while minimizing tissue movement. Unbuffered Dulbecco modified Eagle medium (500 μL) supplemented with 50 μmol/L bovine serum albumin-conjugated palmitic acid, 200 μmol/L L-carnitine, and 2.5 mmol/L D-glucose were then added to each well. At least two replicates from each animal were used for the assay, and each tissue section was examined to ensure absence of large vessels (which can skew oxygen consumption measurements). The plate was incubated at 37°C in a non-CO 2 incubator for 1 hour before extracellular flux analysis. After three baseline measurements, a mixture of antimycin A (10 μmol/L) and rotenone (1 μmol/L) was injected. After injection, the oxygen consumption rate was closely monitored until the rates stabilized, and then the experiment was terminated.
Metabolomic Analysis of Adipose Tissue
Epididymal adipose tissue was used for metabolic analysis. After tissue harvest, the metabolites were extracted in methanol and subjected to metabolic profiling by ultra-high-performance liquid chromatography/tandem mass spectrometry and gas chromatography mass spectrometry. 20, 21 Detailed Methods are provided in the Online Supplement.
Statistical Analyses
Data are mean ± standard error of the mean. Multiple groups were compared using one-way or two-way analysis of variance, followed by Bonferroni posttests. Unpaired Student t test was used for direct comparisons. Statistical analysis of metabolic profiling is described in the Online Supplement; P<0.05 was considered significant.
Results
Nutrient Excess Alters eNOS Abundance
To study the effects of obesity and diabetes on eNOS protein levels, C57BL/6J mice were placed on a high-fat diet, 22 and db/db mice were used as a model of type 2 diabetes. 23 High-fat feeding for 6 and 12 weeks resulted in a profound decrease in eNOS levels in adipose tissue ( Figure 1A , B), with no statistically significant changes in the aorta ( Figure 1A , C) or skeletal muscle (Online Figure IA, B) . Similar changes were observed in 20-week-old db/db mice, in which eNOS in the adipose tissue was undetectable despite a lack of change in eNOS levels in most other tissues. Interestingly, eNOS expression was increased in the hearts of db/db mice (Online Figure IA , C), which might be a compensatory change in response to an increase in NO demand. These data show that both obesity and diabetes result in tissue-specific changes in eNOS expression, with a profound and selective decrease in eNOS levels in the adipose tissue. This decrease in eNOS in adipose tissue is consistent with previous reports in obese humans 24, 25 and in mouse models of obesity, 26 indicating that the expansion of adipose tissue establishes a state of chronic eNOS deficiency.
Overexpression of eNOS Prevents Diet-Induced Obesity
To examine the role of eNOS, we used eNOS-TG mice. 13 Previous studies have shown that these mice reproduce in a Mendelian fashion, maintain normal growth characteristics, and are protected from numerous pathologies, including myocardial, 27 hepatic, 28 lung, 29 and vascular injury, 30 as well as sepsis. 31 In comparison with WT mice, hemizygous mice showed a four-fold increase in eNOS levels in the aorta, with no significant change in eNOS levels in the adipose tissue ( Figure 1D , E). In contrast, in homozygous mice there was a two-fold increase in eNOS in the adipose tissue and a six-fold increase in the aorta. The eNOS in TG animals localized exclusively with isolectin staining (Online Figure II) , indicating that the transgene was expressed only in the vasculature. 13, 32 Plasma from eNOS-TG mice showed increased L-citrulline and nitrite levels when compared with WT mice (Online Figure IIIA , C), and adipose tissue from eNOS-TG mice demonstrated an increase in L-citrulline (Online Figure IIIB) . Because of high variability, there were no significant differences in nitrate or nitrite in adipose tissue (Online Figure  IIID) , perhaps because of other confounding factors, such as nitrite/nitrate found in the diet or reduction of nitrite to NO. When placed on a high-fat diet for 6 weeks, the homozygous eNOS-TG mice gained 50% less weight than WT mice, and this effect persisted for 12 weeks ( Figure 2B , C). Food intake was not different between WT and eNOS-TG mice ( Figure 2D ). A more modest resistance to weight gain also was observed in hemizygous eNOS-TG mice (Online Figure ID) , perhaps because of lower adipose tissue eNOS levels in these mice compared with homozygous eNOS-TG mice. Hence, for all subsequent studies, only eNOS homozygous mice were used. Measurements of body composition by dual-energy X-ray absorptiometry (Dexascan) showed that after 6 weeks of high-fat feeding, the body fat content was much lower in eNOS-TG mice than in nontransgenic mice ( Figure 2E , F). The transgenic mice maintained a higher percent of lean mass ( Figure 2G ), although the tibia length in transgenic mice was only slightly smaller than in WT mice ( Figure 2H ). These observations indicate that overexpression of eNOS decreases adiposity and prevents weight gain induced by high-fat diet.
eNOS Overexpression Increases Whole-Body Metabolism
To determine how eNOS overexpression affected whole-body metabolism, we measured oxygen consumption (Vo 2 ), carbon dioxide production (Vco 2 ), and activity in high-fat-fed WT and eNOS-TG mice over the course of a 12-hour dark period and a 4.5-hour light period. The fact that food intake was not different between WT and TG mice ( Figure 2D ) indicates that the lean phenotype of eNOS-TG mice is not attributable to a decrease in food consumption. This view is reinforced by the observation that high-fat feeding increased plasma cholesterol and leptin to similar levels in WT and eNOS-TG mice (Table) . In comparison with WT mice, eNOS-TG mice showed higher mean Vo 2 and Vco 2 rates throughout the dark and light periods ( Figure 2I , J), with no change in the respiratory exchange ratio ( Figure  2K ). Activity levels assessed by horizontal activity count (beam breaks) showed similar patterns and levels of activity, and total ambulatory activity was not significantly different ( Figure 2L ). Taken together, these observations suggest that on a high-fat diet, eNOS-TG mice maintain a higher metabolic rate than WT mice. This increase in systemic metabolism, however, cannot be attributed to thyroid hormones, because plasma levels of triiodothyronine and thyroxine in WT and eNOS-TG mice were not significantly different (Online Figure IV ).
Effect of eNOS on Diet-Induced Insulin Resistance
Because we found that eNOS overexpression decreased diet-induced weight gain, we expected concurrent changes in insulin resistance. We found that overexpression of eNOS completely prevented diet-induced hyperinsulinemia ( Table  1) , although plasma levels of adiponectin and resistin were not affected. This was associated with a remarkably lower homeostasis model of assessment-insulin resistance score (WT low-fat, 1.45±0.65; WT high-fat, 34.4±5.3; P<0.05 vs WT low-fat; TG low-fat, 6.9±3.1; TG high-fat, 8.2±2.9; P<0.05 vs WT high-fat). Moreover, even though 6 weeks of high-fat feeding did not significantly increase triglycerides or plasma nonesterified free fatty acids, both of these were decreased by 50% in the TG mice compared with WT mice (Table 1) . We did not find significant differences in plasma glycerol between the groups ( Table 1 ), suggesting that adipose tissue lipolysis was not affected. Other parameters measured in the plasma are shown in Online Table I . Collectively, these data indicate that overexpression of eNOS prevents high-fat diet-induced hyperinsulinemia and decreases plasma triglycerides and fatty acids.
To examine how eNOS overexpression affects systemic glucose disposal, WT and eNOS-TG mice were placed on a high-fat diet for 6 weeks, and glucose and insulin tolerance tests were performed. There was no significant difference in the basal blood glucose levels in nonfasted WT and eNOS-TG mice ( Figure 3A) . After a fast of 6 hours, the plasma glucose levels of both high-fat-fed groups were significantly increased compared with the WT low-fat-fed group. Fasting for 16 hours resulted in near-normalization of blood glucose in WT mice; however, glucose levels in the eNOS-TG mice remained slightly, but significantly, elevated ( Figure 3A ). There were no significant differences in plasma HbA1c in any group ( Figure 3B ). Measurements of insulin resistance by glucose tolerance test indicated that, in both WT and eNOS-TG mice, high-fat diet led to an increase in the glucose tolerance test area under the curve, indicating the onset of insulin resistance ( Figure 3C -E). The early increase in glucose levels in both the low-fat-fed and highfat-fed groups showed a slight but significant increase in blood glucose in TG mice ( Figure 3C , D); however, there were no significant differences when area under the curve was compared ( Figure 3E ). Measurements of insulin tolerance ( Figure  3F -H) showed no significant difference in glucose disposition in any of the groups.
To test whether the effects of the transgene would manifest after prolonged feeding, we placed WT and eNOS-TG mice on high-fat diet for 12 weeks and assessed insulin resistance. At completion of the feeding protocol, the glucose tolerance test and insulin tolerance test curves were superimposable, suggesting that eNOS overexpression does not affect diet-induced insulin resistance even after prolonged nutrient excess (Online Figure VA-D) . Although, plasma glucose levels in nonfasted and 6-hour fasted mice were not statistically different, a 16-hour fast led to a greater decrease in blood glucose in WT compared with TG mice (Online Figure   Figure 2 . Endothelial nitric oxide synthase (eNOS) prevents diet-induced obesity.Weight gain, adiposity, and indirect calorimetry measurements from wild-type (WT) and eNOS transgenic (eNOS-TG) mice fed a lowfat diet (LFD) or high-fat diet (HFD). A, Body weights during 6 weeks of LFD feeding; n=22 to 26 per group. B, Body weights during 6 weeks of HFD feeding; n=26 per group. C, Summarized weight gain over the course of 6 weeks and 12 weeks of HFD feeding; n=28 to 29 per group for 6-week group and n=4 to 7 per group for 12-week group. D, Food intake, n=4 per group. E, Representative DexaScan images of mice fed LFD or HFD for 6 weeks. F, Body fat percentage, n=8 to 12 per group. G, Lean mass percentage, n=8 to 12 per group. H, Tibia length for mice fed LFD or HFD for 6 weeks, n=8 to 12 per group. I, Average oxygen consumption (Vo 2 ). J, Average carbon dioxide production (Vco 2 ). K, Respiratory exchange ratio (RER). L, Ambulatory counts, n=4 per group. *P<0.05, **P<0.01, and ***P<0.001 vs indicated groups; # P<0.05 vs WT HFD. VE), indicating that the TG mice were more resistant to starvation-induced hypoglycemia, which could be attributable to increased gluconeogenesis in the liver. To test this, we performed pyruvate tolerance tests, which did not show remarkable differences between WT and TG mice (Online Figure VF , G), indicating that resistance to hypoglycemia in TG mice may not be attributable to increased hepatic production of glucose. Collectively, these data suggest that eNOS eNOS indicates endothelial nitric oxide synthase; HFD, high-fat diet; LFD, low-fat diet; NEFA, nonesterified free fatty acids; TG, transgenic; WT, wild-type.
WT and eNOS-TG mice were fed LFD or HFD for 6 wk. Plasma from the mice was used to measure the indicated parameters. *n=6 to 7 mice per group. For all other parameters, the groups contained 13 to 14 mice per group; †WT LFD vs WT HFD; ‡WT LFD vs eNOS-TG LFD; §WT LFD vs eNOS-TG HFD; ¶WT HFD vs eNOS-TG LFD; WT HFD vs eNOS TG HFD; **eNOS-TG LFD vs eNOS-TG HFD. October 12, 2012 overexpression does not significantly affect diet-induced insulin resistance or glucose intolerance, but maintains glucose homeostasis during starvation.
Effect of eNOS on Adipose Tissue
Given our observations that obesity and diabetes were associated with a selective decrease of eNOS levels in adipose tissue and that eNOS-TG mice were resistant to diet-induced weight gain, we measured changes in adipocyte area and size in epididymal fat pads. These measurements revealed that high-fat diet induced adipocyte hypertrophy, leading to a three-fold to four-fold increase in mean adipocyte area ( Figure 4A,  B) . Moreover, the high-fat diet promoted size heterogeneity in WT, but not eNOS-TG mice ( Figure 4C ), indicating that eNOS overexpression prevents diet-induced adipocyte hypertrophy and size dispersion.
In murine models of diet-induced obesity, adipocyte hypertrophy is associated with inflammation and accumulation of macrophages in adipose tissue. 33 This is commonly recognized by the presence of crown-like structures that appear between adipocytes. 18, 33, 34 In humans, obesity is similarly associated with adipose tissue inflammation, and weight loss interventions such as bariatric surgery improve endothelial function. 35, 36 Therefore, we examined adipose tissue inflammation in WT and eNOS-TG mice after 6 weeks of high-fat diet. Analysis of adipose tissue showed no significant difference in the abundance of crown-like structures between WT and TG mice ( Figure 4A ), and analysis of the adipose tissue stromal vascular fractions showed no difference in total F480 + cells or changes in macrophage subtypes (Online Figure VI) . These results are in accordance with studies showing that macrophage accumulation and insulin resistance occur only with prolonged high-fat feeding (>10 weeks) 22, 37 and suggest that the antihypertrophic effects of eNOS are not associated with significant changes in adipose tissue inflammation, but are likely to be related to favorable changes in metabolism that prevent lipid accumulation and adipocyte expansion.
Metabolic Changes in Adipose Tissues of eNOS-Overexpressing Mice
The lean phenotype of eNOS-TG mice and their resistance to diet-induced weight gain and adipocyte expansion clearly indicated to us that eNOS overexpression has a significant impact on adipocyte metabolism. Therefore, to assess this impact, we measured metabolite levels in epididymal adipose tissue of high-fat-fed WT and eNOS-TG mice using ultrahigh-performance liquid chromatography/tandem mass spectrometry and gas chromatography mass spectrometry. Spectral data were identified, searched against a standard library, and quantified (see Online Supplement and Online Figure VII for details). Internal standards, including injection standards, process standards, and alignment standards were used for quality control and to control for experimental and instrument variability. This analysis led to the identification of 192 metabolites, of which 37 were significantly different between WT and eNOS-TG mice ( Figure 5A and Online Table II ). Although intermediates in the glycolytic pathway and the citric acid cycle were not affected, there were significant increases in propionylcarnitine, acetylcarnitine, 3-dehydrocarnitine, and isobutyrylcarnitine, some of which have been shown to stimulate fatty acid oxidation. 38, 39 Higher levels of amino acids such as threonine, methionine, valine, isoleucine, and leucine were also observed in TG mice (Online Table II ). Multivariate and cluster analyses showed that these changes were determining factors in the separation of the groups (Figure 5B, C) , and pathway impact analysis ( Figure 5D ) suggested that the changes in amino acid synthesis and degradation may be important features regulating the lean phenotype of eNOS-TG mice. Plotting of the z-scores of metabolites from adipose tissues of eNOS-TG and WT mice showed increases in short-chain acylcarnitines as well as amino acids and their degradation products ( Figure 6A ). Metabolites correlating with citrulline levels showed a similar pattern of metabolites ( Figure 6B ). The adipose tissue metabolites in eNOS-TG mice shown to be significantly different from WT mice equated to differences in urea cycle/arginine metabolism, branched chain amino acid metabolism, carnitine metabolism, purine metabolism, oxidative phosphorylation, and fatty acid metabolism subpathways ( Figure 6C ). Taken together, changes in metabolite levels in the adipose tissue indicated that overexpression of eNOS stimulates amino acid and fatty acid metabolism in adipose tissue.
Adipose Tissue Mitochondria Are Increased in eNOS-TG Mice
Favorable changes in branched chain amino acid and fatty acid metabolism are indicative of increased mitochondrial activity. Previous studies have shown that branched chain amino acids increase mitochondrial biogenesis, and that this is attenuated in eNOS-null mice. 40 In addition, it has been reported that NO triggers mitochondrial biogenesis in adipocytes and that deletion of eNOS decreases mitochondrial content in adipose tissue. 41 Based on this evidence, we hypothesized that the change in branched chain amino acids and fatty acid metabolism in the adipose tissue of eNOS-TG mice may be related to greater mitochondrial content. Adipose tissue, but not skeletal muscle, from eNOS-TG mice showed significant increases in key mitochondrial proteins such as COX4I1, Sirt3, and ALDH2 ( Figure 7A, C) . The increase in mitochondrial proteins in TG adipose tissue could be attributable to remodeling of the mitochondria or an increase in mitochondrial abundance. To distinguish between these possibilities, sections of adipose tissue were stained with a nonmembrane potential-dependent mitochondrial stain, mitoID-Red. As shown in Figure 7E , adipose tissue isolated from high-fat-fed eNOS-TG mice stained more strongly than that from WT mice, indicating that the adipose tissue mitochondrial content was higher in TG than in WT mice. Adipocytes isolated from high-fat-fed eNOS-TG mice were more brown than those isolated from WT mice ( Figure 7F ), suggesting an increase in mitochondrial cytochromes. In addition to increased abundance of COX4I1 ( Figure 7A, C) , the expression of the mitochondrial gene cytochrome, cytochrome b6 (cytb6), was elevated two-fold in eNOS-TG mice (cytb6:gapdh ratios, fold change: WT, 1.0±0.1; eNOS-TG, 2.0±0.3; n=4-7/group; P<0.05). That this increase in mitochondrial content may be attributable to increased biogenesis is supported by our observation that in comparison with WT mice, TG mice had higher adipose levels of peroxisome proliferator-activated receptor-gamma coactivator 1 alpha, as well as an increase in pparα and pparγ ( Figure 7G ), factors that are important activators of mitochondrial biogenesis. [42] [43] [44] [45] [46] [47] 
Effect of eNOS on Adipose Tissue Metabolic Flux
To assess the functional implications of our observations, we measured oxygen consumption in adipose tissue explants using extracellular flux technology. As shown in Figure 8B , adipose tissue from eNOS-TG mice showed a significantly higher oxygen consumption rate compared with adipose tissue from WT mice. To determine the contribution of mitochondria to the oxygen consumption rate, we treated the explants with the electron transport chain inhibitors antimycin A and rotenone. The stabilized rate measured thereafter was used to calculate the mitochondria-derived oxygen consumption rate, which was two-fold higher in eNOS-TG compared with WT adipose tissue ( Figure 8C ). No statistically significant difference was observed in the extracellular acidification rate, a surrogate index of glycolysis ( Figure 8D ). Collectively, these observations corroborate our metabolic, biochemical, and Metabolomic analyses of epididymal adipose tissue metabolites from wild-type (WT) and endothelial nitric oxide synthase transgenic (eNOS-TG) mice fed high-fat diet (HFD) for 6 weeks. A, Univariate analysis: t tests of compounds from adipose tissues. All metabolites above the dotted line were found to be significantly different between WT and eNOS-TG mice (P<0.05). A table of these metabolites can be found in the Data Supplement (Online Table II ). B, Multivariate analysis: partial least-squares discriminant analysis (PLS-DA). C, Hierarchial clustering: heatmap and dendogram using the most significantly different metabolites. D, The significant metabolites were subjected to pathway impact analysis using Metaboanalyst MetPA and the Mus musculus pathway library. Fisher exact test was used for overrepresentation analysis, and relative between-ness centrality was used for pathway topology analysis. n=14 animals: 7 WT HFD, 7 eNOS-TG HFD. October 12, 2012 anatomic measurements by demonstrating directly that the adipose tissue of eNOS-TG mice maintains a hypermetabolic state that could at least partially account for their increase in whole-body oxygen consumption and resistance to obesity.
Discussion
The major findings of this study are that high-fat diet results in the downregulation of eNOS in adipose tissue and that overexpression of eNOS prevents diet-induced obesity. These findings support a causal role of eNOS in regulating obesity and whole-body metabolism. Our results suggest that the mechanism of this antiobesogenic effect of eNOS is related to an increase in whole-body oxygen consumption associated with increased mitochondrial abundance and activity in the adipose tissue. Collectively, these observations support the notion that NO is an important regulator of adipocyte metabolism and therefore weight gain attributable to a high-fat diet. Although it has been shown before that deletion of eNOS gives rise to features of metabolic syndrome, 11 the rescue of the obese phenotype by increasing eNOS indicates that enhancing eNOS expression can overcome the metabolic changes caused by consumption of high-fat diet.
Several lines of evidence gathered during this study support the view that the antiobesogenic effects of eNOS are attributable to favorable changes in adipocyte metabolism. Although on the basis of current results we cannot rule out or even fully assess all potential systemic effects, our observations that food consumption, activity, plasma levels of cholesterol, leptin, and thyroid hormones were not different between WT and TG mice argue against a global systemic change that could completely account for the lean phenotype of the TG mice. Both insulin resistance and obesity are complex phenotypes that are regulated by multiple interactions between several tissues, some or all of which might be affected in a manner not captured by our current analysis. Nevertheless, in regulating obesity, the adipose tissue appears to be a major target of eNOS. Our gene-dosage studies show that despite a four-fold increase in eNOS in the aorta, diet-induced obesity was only marginally affected in eNOS hemizygous mice, in which there was no increase in eNOS in adipose tissue. Only in homozygous mice, in which eNOS was increased both in adipose tissue and aorta, did the antiobesogenic effects of eNOS become apparent. This association of the lean phenotype with eNOS expression in adipose tissue supports the view that an increase in NO in adipose depots may be required for the manifestation of the antiobesogenic effects of eNOS.
How does eNOS regulate adipose tissue metabolism? Our results suggest that eNOS supports both mitochondrial Metabolite analysis from adipose tissues of wild-type (WT) and eNOS transgenic (eNOS-TG) mice fed high-fat diet (HFD) for 6 weeks. A, The z-score plots of significantly changed metabolites. B, Correlation analysis was assessed using the Spearman rank correlation test, and the metabolites that correlated with citrulline were then examined. C, Superpathway and subpathway distribution of adipose tissue metabolites found to be significantly different between WT and eNOS-TG mice. n=14 animals: 7 WT HFD and 7 eNOS-TG HFD.
biogenesis and metabolic activity. Previous observations showing that β-oxidation is impaired in eNOS-null mice 12 and that dietary supplementation with the NO precursor nitrite reverses features of metabolic syndrome in eNOS-null mice 48 are supportive of this concept. Although AMP kinase has been shown to relate with NO levels, 49, 50 we did not find an increase in the phosphorylation state of AMP kinase in adipose tissue (Online Figure VIII) . However, we did find elevated levels of several metabolites such as branched chain amino acids and short-chain acylcarnitines (eg, acetylcarnitine, proprionylcarnitine) in the adipose tissue of TG mice that were indicative of high metabolic activity. Interestingly, oral supplementation with proprionylcarnitine reduces obesity and hyperinsulinemia in obese rats, 51 which at least partially recapitulates the phenotype of eNOS-TG mice. We also found in the adipose tissue of TG mice elevated levels of proteins such as peroxisome proliferator-activated receptor-gamma coactivator 1 alpha and Sirt3 and increased expression of ppara and pparg that regulate mitochondrial activity, fatty acid oxidation, and biogenesis. [42] [43] [44] [45] [46] [47] 52, 53 That the increase in these proteins was functionally significant is reflected by our observations that mitochondrial abundance and the rates of fatty acid oxidation were higher in the adipose tissue from eNOS-TG mice. On the basis of these observations, we propose that high levels of eNOS lead to an increase in mitochondrial biogenesis and stimulation of fatty acid oxidation. This establishes a state of heightened metabolism that attenuates the obesogenic effects of high fat consumption.
Although our results show that eNOS overexpression increases adipose tissue metabolism by increasing mitochondrial content and activity, metabolic activity also could be affected by eNOS-dependent changes in oxygen distribution. Hence, it is possible that adipocytes of eNOS-TG mice are better-perfused than those of WT mice. Such an increase in tissue perfusion could be attributable to either regulatory effects on vascular tone 54 and O 2 consumption 55 or an increase in angiogenesis. 56 Nevertheless, we found that capillary density was unaffected by eNOS overexpression, because isolectin B4 staining per adipocyte and VEGFR2 expression were similar between the groups (Online Figure IX) , suggesting that an increase in angiogenesis is unlikely to be a reason underlying the lean phenotype of eNOS-TG mice.
The metabolic role of eNOS, however, appears to be tissue-specific. We found that high-fat feeding decreased eNOS in the adipose tissue but not in the heart or the skeletal muscle. Hence, we expected that overexpression of eNOS would ameliorate adipose tissue hypertrophy without These results showed that high-fat-induced changes in glucose disposal were not different between WT and eNOS-TG mice, indicating that whole-body glucose metabolism, which is regulated primarily by glucose uptake by the skeletal muscle, 57 was not related to changes in eNOS levels. Nevertheless, the observation that despite their lean phenotype the TG mice develop insulin resistance is significant because a lean phenotype characterized by the browning of fat is usually associated with improved glucose tolerance. [58] [59] [60] [61] It is likely that a decrease in eNOS is a critical event in adipose tissue but not skeletal muscle, and therefore elevated levels of eNOS in the adipose tissue prevent obesity without affecting systemic insulin resistance.
Results showing that overexpression of eNOS prevents obesity without affecting insulin resistance also suggest that the two symptoms of metabolic syndrome could be dissociated from one another. Similar segregation between obesity and insulin resistance has been described previously. For instance, it has been shown that overexpression of adiponectin completely rescues the diabetic phenotype of ob/ob mice while promoting morbid obesity. 62 Moreover, the observations that decreasing inflammation [63] [64] [65] does not result in lower adiposity but improves insulin sensitivity, and that PPARγ agonists decrease insulin resistance but increase weight gain 8 provide additional support to the concept that obesity and diabetes are disconnected and, in some cases, even conflicting events in the etiology of metabolic disease. However, it remains to be established how eNOS prevents hyperinsulinemia and impacts other processes that are associated with insulin resistance, such as inflammation. It is currently believed that because of excessive adipocyte expansion, hypoxia and necrosis occur in adipose tissue, which in turn leads to the recruitment of inflammatory cells. 66, 67 The resultant low-grade chronic inflammation is proposed to establish a state of insulin resistance. 68, 69 However, the eNOS-TG mice develop the antiobesogenic phenotype far before macrophage infiltration, inflammation, and insulin resistance in adipose tissue occur. 22, 37 It is important to note that the eNOS-TG mice did not display a lipodystrophic phenotype. Lipodystrophy in humans and animal models generally results in severe hypertriglyceridemia, hyperinsulinemia, and insulin resistance. [70] [71] [72] The eNOS-TG mice, however, show decreased triglycerides and were protected from hyperinsulinemia despite development of diet-induced glucose intolerance. The prevention of hyperinsulinemia does not appear to be attributable to a pancreatic defect; baseline insulin levels were not significantly different from WT mice (Table 1) , the glucose tolerance test showed a normal profile (Figure 3 and Online Figure V) , and the pancreatic islets from eNOS-TG mice appeared unremarkable (Online Figure X) . These observations raise the interesting possibility that hyperinsulinemia in response to systemic insulin resistance may be partly regulated by the adipose tissue, although additional work is required to fully understand this relationship.
Additional investigations also will be required to assess how high-fat diet affects eNOS activity and expression. Although it has been shown that eNOS levels are suppressed in high-fat diet in part because of tumor necrosis factor-αdependent mechanisms, 26 the effects of diet on eNOS protein and activity are less clear. The eNOS protein is subject to several posttranslational modifications, including phosphorylation, 73 O-GlyNAcylation, 74 S-glutathiolation, 75 and acylation. 76, 77 In addition, the enzyme also could be uncoupled and therefore generate superoxide instead of synthesizing NO. Interestingly, we found that whereas eNOS monomer abundance was maintained in eNOS-TG mice (Online Figure XI) , the phosphorylation of eNOS at Ser 1177 and abundance of the eNOS dimer were significantly decreased in both WT and TG mice fed a high-fat diet (Online Figure XI ). Although these changes in the eNOS-TG mice After three baseline measurements, antimycin A and rotenone (AA/ Rot) were injected to identify the mitochondria-dependent OCR. C, Mitochondrial OCR calculated from measurements in (B). D, Extracellular acidification rate (ECAR) measured from adipose explants. ECAR is a surrogate measure of glycolytic rate; n=3 to 4 per group. *P<0.05 vs WT. might be compensated by continually elevated levels of eNOS protein, as evidenced by persistently elevated citrulline levels (Online Figure IIIA, B ), such changes in WT mice might result in a chronic state of NO deficiency. Moreover, uncoupling of the enzyme could lead to increased superoxide production and the formation of the toxic metabolite peroxynitrite. We found increased nitrotyrosine formation in adipose tissue of high-fat-fed mice (Online Figure XII) , although this was not significantly affected by eNOS overexpression. Hence, in future studies it will be important to identify the processes that regulate eNOS activity and how they might be involved in the development of diet-induced obesity and insulin resistance.
In conclusion, the present study shows that preventing eNOS depletion by forced expression of the eNOS transgene attenuates diet-induced obesity in mice, without ameliorating systemic insulin resistance. These findings reveal a novel antiobesogenic role of eNOS and are consistent with the notion that eNOS prevents weight gain in high-fat-fed mice by stimulating mitochondrial biogenesis and activity in adipose tissues. Further understanding of this role of eNOS could lead to the development of new therapeutic modalities for preventing obesity and weight gain in human populations.
What Is Known?
• Obesity is positively and robustly associated with the risk of development of cardiovascular disease and diabetes. • Vascular dysfunction and, in particular, deficits in endothelial-derived nitric oxide (NO) production and bioavailability are associated with insulin resistance, adiposity, and deleterious changes in metabolism.
What New Information Does This Article Contribute?
• The expression of endothelial NO synthase (eNOS) in adipose tissue is decreased in mouse models of obesity and type 2 diabetes. • Transgenic overexpression of eNOS in mice decreases circulating fatty acids and prevents obesity and hyperinsulinemia induced by a high-fat diet. • Overexpression of eNOS prevents adipocyte hypertrophy, increases mitochondrial abundance and activity, and regulates branched chain amino acid metabolism.
Vascular dysfunction and decreased NO bioavailability are associated with metabolic syndrome; however, the therapeutic effects of increasing endogenous NO production have not been tested, and the effects of NO on metabolism are poorly understood. We show here that consumption of a high-fat diet decreases the abundance of eNOS in adipose tissue and that increasing eNOS expression prevents diet-induced obesity. The antiobesity effect of eNOS was associated with enhanced mitochondrial activity and significant changes in amino acid and lipid metabolism in adipose tissue. These findings suggest that eNOS prevents obesity by increasing the ability of adipocytes to burn excess fat. This novel regulation of adipocyte phenotype adds to our growing knowledge of the plasticity of adipose tissue and suggests that eNOS could regulate brown or beige-like gene programs. Thus, increasing NO availability or production may be an important therapeutic strategy for preventing obesity and its cardiovascular complications.
